These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 13845611)

  • 1. Potentiation of 5-fluorouracil by combination chemotherapy in animals.
    WOLBERG WH; CURRERI AR
    Cancer Chemother Rep; 1960 Feb; 6():6-7. PubMed ID: 13845611
    [No Abstract]   [Full Text] [Related]  

  • 2. A clinical study of 5-fluorouracil.
    GOLD GL; HALL TC; SHNIDER BJ; SELAWRY O; COLSKY J; OWENS AH; DEDERICK MM; HOLLAND JF; BRINDLEY CO; JONES R
    Cancer Res; 1959 Oct; 19():935-9. PubMed ID: 13850554
    [No Abstract]   [Full Text] [Related]  

  • 3. 5-Fluorouracil and its ribosides.
    WHITE FR
    Cancer Chemother Rep; 1960 Feb; 6():94-114. PubMed ID: 13844347
    [No Abstract]   [Full Text] [Related]  

  • 4. [Research on the antimitotic properties of antagonists of natural pyrimidine bases. I. 5-Fluorouracil and related compounds].
    DEYSSON G; TRUHAUT R
    Bull Soc Chim Biol (Paris); 1962; 44():513-24. PubMed ID: 13885944
    [No Abstract]   [Full Text] [Related]  

  • 5. Biochemical changes during treatment with 5-fluorouracil.
    REICHARD P
    Cancer Chemother Rep; 1962 Feb; 16():347-52. PubMed ID: 14491142
    [No Abstract]   [Full Text] [Related]  

  • 6. Combined action of 5-fluorouracil and other cytotoxic agents with crystalline ribonuclease on mouse ascites tumor.
    PODOLSKY S; WASE AW; CARDENAS J
    Henry Ford Hosp Med Bull; 1961 Dec; 9():583-94. PubMed ID: 14487340
    [No Abstract]   [Full Text] [Related]  

  • 7. The action of 5-fluorouracil on the nucleic acid metabolism of pseudorabies virus-infected and noninfected rabbit kidney cells.
    KAPLAN AS; BEN-PORAT T
    Virology; 1961 Jan; 13():78-92. PubMed ID: 13751263
    [No Abstract]   [Full Text] [Related]  

  • 8. The clinical pharmacology of the oral fluoropyrimidines.
    Takimoto CH
    Curr Probl Cancer; 2001; 25(3):134-213. PubMed ID: 11408845
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical evaluation of cancer chemotherapy with 5-fluorouracil.
    VAITKEVICIUS VK; BRENNAN MJ; BECKETT VL; KELLY JE; TALLEY RW
    Cancer; 1961; 14():131-52. PubMed ID: 13779639
    [No Abstract]   [Full Text] [Related]  

  • 10. The influence of fluorouracil containing compounds upon growth and metabolism of Bacillus cereus.
    SELLS BH
    Arch Int Physiol Biochim; 1959 Jun; 67(3):532-3. PubMed ID: 13670690
    [No Abstract]   [Full Text] [Related]  

  • 11. [Problems in chemotherapy illustrated by the cytostatic 5-fluoruracil and the leukemias].
    OBRECHT P
    Strahlentherapie; 1961; Suppl 48():65-73. PubMed ID: 14481028
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of far-advanced cancer with 5-fluorouracil, used alone and in combination with irradiation. Incidence and duration of remission and survival-time data in 223 patients.
    HALL BE; GOOD JW
    Cancer Chemother Rep; 1962 Feb; 16():369-86. PubMed ID: 13903837
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical experience with 5-fluorouracil.
    KNOEPP LF; KASTL WH; RAYBURN AL; SAYEGH SF; LETSON WM
    Cancer Chemother Rep; 1961 Jun; 12():89-97. PubMed ID: 13757166
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical experiences with 5-fluorouracil.
    CALABRESI P; BRODY JI; PERILLIE PE; FINCH SC
    Conn Med; 1960 Jul; 24():415-21. PubMed ID: 13806845
    [No Abstract]   [Full Text] [Related]  

  • 15. 5-Fluorouracil in clinical cancer experience with 155 patients.
    BRENNAN MJ; VAITKEVICIUS VK
    Cancer Chemother Rep; 1960 Feb; 6():8-11. PubMed ID: 13804187
    [No Abstract]   [Full Text] [Related]  

  • 16. A preliminary report on the use of 5-fluorouracil in malignant disease.
    BAINES CJ; LEY DC
    Can Med Assoc J; 1962 Feb; 86(5):207-10. PubMed ID: 13864054
    [No Abstract]   [Full Text] [Related]  

  • 17. Intra-arterial infusion of maligancies with 5-fluorouracil.
    TARR N; SENSENBRENNER LL; FLETCHER R; GRIFFING J
    Cancer Chemother Rep; 1961 Oct; 14():23-37. PubMed ID: 13919702
    [No Abstract]   [Full Text] [Related]  

  • 18. Factors to be considered in the clinical evaluation of a new chemotherapeutic agent (5-fluorouracil).
    HYMAN GA; ULTMANN JE; HABIF DV
    Cancer Chemother Rep; 1962 Feb; 16():397-9. PubMed ID: 14450340
    [No Abstract]   [Full Text] [Related]  

  • 19. Various methods of administering 5-fluorouracil.
    STALEY CJ; HART JT; VAN HAGEN F; PRESTON FW
    Cancer Chemother Rep; 1962 Jul; 20():107-12. PubMed ID: 13916123
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of 5-fluorouracil in disseminated solid neoplasms.
    ROCHLIN DB; SHINER J; LANGDON E; OTTOMAN R
    Ann Surg; 1962 Jul; 156(1):105-13. PubMed ID: 14493052
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.